Ademi LLP is investigating Cellebrite for potential securities fraud related to inaccurate statements about its financials, business operations, and prospects. The probe focuses on Cellebrite's disclosures about risks and challenges in securing U.S. federal and European government contracts due to additional administrative and procurement hurdles linked to its foreign-entity status. This investigation could impact investor confidence and future government business opportunities for Cellebrite. Investors can contact Ademi LLP for more information or to join the investigation at no cost.
Zeta Global's stock surged 69% over the past three months, significantly outperforming its benchmark's 4% gain. The company’s accelerating business performance, especially in AI-powered services, supports continued optimism about its future prospects...
Primo Brands Corporation received a BUY rating following robust second-quarter 2026 results, improved operating leverage, and a favorable valuation discount. The company raised its 2026 sales guidance to 2–4% growth, driven by strong premium brand pe...
Wistron Corporation's shares fell over 6% after announcing a $1.47 billion global depositary receipt offering to raise funds for raw material purchases. The offering involves 25 million receipts priced at a 5.5% discount, representing about 7.29% of ...
A British man known as Chris reclaimed 61 BTC worth $4.4 million after 12 years of legal battle following the 2014 collapse of Intersango, a UK bitcoin exchange. Initially buying bitcoin in 2011, Chris left his coins in the exchange custody, which sh...
XPENG has started operating the world's first advanced humanoid robot production lines, successfully transitioning from R&D to mass manufacturing. Their humanoid robot, IRON, features high dexterity, AI intelligence, and automotive-grade quality, des...
